Preventive effects of polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols

Molecular Cancer Therapeutics

Volumn 6, Issue 7, 2007, Pages 2022-2028

  Lubet, Ronald A ^a   Yang, Chung S ^b   Lee, Mao Jung ^b   Hara, Yukihiko ^c   Kapetanovic, Izet M ^a   Crowell, James A ^a   Steele, Vernon E ^a   Juliana, M Margaret ^d   Grubbs, Clinton J ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c Mitsui Norin LTD ^*  (Japan)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; EPICATECHIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; METHYLNITROSOUREA; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; POLYPHENOL DERIVATIVE; POLYPHENON E; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER MODEL; CANCER PREVENTION; CONTROLLED STUDY; CORRELATIONAL STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG URINE LEVEL; FEMALE; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; RAT; TEA;

ANIMALS; CATECHIN; FEMALE; FLAVONOIDS; MAMMARY NEOPLASMS, EXPERIMENTAL; PHENOLS; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; TEA; URINARY BLADDER NEOPLASMS;

EID: 34447326971     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-07-0058     Document Type: Article

References (29)

1. Grubbs CJ, Moon RC, Squire RA, et al. 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N- (4-hydroxybutyl)-nitrosamine. Science 1977;198:743-4.
2. Becci PJ, Thompson HJ, Strum JM, et al. N-Butyl-N-(4- hydroxybutyl)-nitrosamine induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids. Cancer Res 1981;41:927-32.
3. Grubbs CJ, Lubet RA, Koki AT, et al. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in male B6D2F1 mice and female Fischer-344 rats. Cancer Res 2000;60:5599-602.
4. Okajima E, Denda A, Ozono S, et al. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 specific inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4- hydroxybutyl)-nitrosamine. Cancer Res 1998;58:3028-31.
5. Huggins C, Grand LC, Brillantes FP. Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature 1961;189:204-7.
6. Grubbs CJ, Peckham JC, Cato KD. Mammary carcinogenesis in rats in relation to age at time of N-nitroso-N-methylurea administration. J Natl Cancer Inst 1983;70:209-12.
7. Chan MM, Lu X, Merchant FM, Inglehart JD, Miron PL. Gene expression profiling of NMU-induced rat mammary tumors: cross species comparison with human breast cancer. Carcinogenesis 2005;26:1343-53.
8. Lubet RA, Christov K, You M, et al. Effects of the farnesyltransferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis, prevention, therapy and the role of HaRas mutations. Mol Cancer Ther 2006;5:1073-8.
9. Lubet RA, Christov K, Nunez NP, et al. Efficacy of Targretin on MNU-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosis. Carcinogenesis 2005;25:441-8.
10. Liao J, Yang GY, Park ES, et al. Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr Cancer 2004;48:444-53.
11. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002;42:25-54.
12. Lambert JD, Hong J, Yang G-Y, Liao J, Yang CS. Inhibition of carcinogenesis by polyphenols evidence from laboratory investigations. Am J Clin Nutr 2005;81:284-91S.
13. Sato D, Matsushima M. Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea leaves. Int J Urol 2003;10:160-6.
14. Sato D. Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea. Int J Urol 1999;6:93-9.
15. Hirose M, Hoshiya T, Akag K, Futakuchi M, Ito N. Inhibition of mammary glad carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7, 12 dimethylbenz[a]anthracene. Cancer Lett 1996;83:149-56.
16. Kavanagh KT, Hafer LJ, Kim DW, et al. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem 2001;82:387-98.
17. Whitsett T, Carpenter M, Lamartiniere CA. Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J Carcinog 2006;5:5-15.
18. Lee MJ, Prabha S, Meng X, Yang CS. An improved method for the determination of green and black tea polyphenols in biomatrices by high- performance liquid chromatography with cuolometric array detection. Anal Biochem 2000;279:164-9.
19. Chen L, Lee M-J, Li H, Yang CS. Absorption, distribution, and elimination of tea polyphenols in rats. Drug Metab Dispos 1997;25:1045-50.
20. Lubet RA, Huebner K, Fong LY, et al. 4-Hydroxybutyl(butyl)-nitrosamine (OH-BBN) induced urinary bladder cancers in mice: Characterization of FHIT, survivin expression and chemopreventive effects of indomethacin. Carcinogenesis 2005;26:571-8.
21. Yao R, Yi Y, Grubbs CJ, Lubet RA, You M. Gene expression profiling of chemically induced rat bladder tumors. Neoplasia 2007;9:207-21.
22. Gee J, Sabichi AL, Grossman HB. Chemoprevention of superficial bladder cancer. Crit Rev Oncol Hematol 2002;43:277-86.
23. Yang G-Y, Liao J, Kim K, Yurkow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 1998;19:611-6.
24. Lambert JD, Rice JE, Hong J, Hou Z, Yang CS. Synthesis and biological activity of the tea catechin metabolites, M4 and M6 and their methyoxy-derivatives. Bioorg Med Chem Lett 2005;15:873-6.
25. Hou Z, Lambert JD, Chin K-V, Yang CS. Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention. Mutat Res 2004;555:3-19.
26. Sang S, Lambert JD, Yang CS. Bioavailability and stability issues in understanding the cancer preventive effects of tea polyphenols. J Sci Food Agric 2006;86:2256-65.
27. Yang CS, Lambert JD, Hou Z, Ju J, Lu G, Hao X. Molecular targets for the cancer preventive activity of tea polyphenols. Mol Carcinog 2006;4:431-5.
28. Masuda M, Suzui M, Lim LT, Weinstein IB. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res 2003;9:3486-91.
29. Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L. ( - ) Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 2005;11:2735-46.